Literature DB >> 1376969

Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis.

K E Wisniewski1, W Gordon-Majszak, S Maslinski, J Heaney-Kieras.   

Abstract

The neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative diseases characterized by massive intralysosomal accumulation of storage materials. We have studied the protein patterns in 5 NCL, 5 control, and one Alzheimer disease brains. When protein patterns in NCL and control brain gray matter homogenates were examined by SDS-PAGE, NCL brains showed an absence or greatly reduced amounts of the Mr 160-180 kDa component and reduced amounts of the Mr 29-36 kDa component. Concomitantly, an increase in several components with Mrs of 45-50 kDa was noted. The 180 kDa polypeptide appears to be a glycoprotein because it was bound to the lectins concanavalin A and Ulex europaeus. Recently, the abnormal processing of amyloid protein precursor (APP) and its potential role in NCL have been suggested. Possible defects in tissue proteases and protease inhibitors may be considered responsible for the presence of these amyloid beta protein precursor fragments. To examine this possibility we are using polyclonal antibodies to the C terminal 672-695 (APP) and monoclonal antibodies to inter-alpha-trypsin inhibitor. Polypeptides with molecular weights of approximately 35-38 kDa were detected in the NCL brain, but not in controls in both cases. These findings suggest abnormal protein processing in NCL brain tissue, disturbances in protein and glycoconjugate metabolism, impaired lysosomal function (i.e., metabolic enzyme and/or proteases/proteinase inhibitor abnormalities), and the involvement of improperly processed APP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376969     DOI: 10.1002/ajmg.1320420429

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Abnormal processing of carboxy-terminal fragment of beta precursor protein (beta PP) in neuronal ceroid-lipofuscinosis (NCL) cases.

Authors:  K E Wisniewski; W Gordon-Krajcer; E Kida
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 2.  Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).

Authors:  Jacqueline A Hawkins-Salsbury; Jonathan D Cooper; Mark S Sands
Journal:  Biochim Biophys Acta       Date:  2013-06-06

3.  S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.

Authors:  Sandra Codlin; Sara E Mole
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

4.  Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses.

Authors:  Ni Sima; Rong Li; Wei Huang; Miao Xu; Jeanette Beers; Jizhong Zou; Steven Titus; Elizabeth A Ottinger; Juan J Marugan; Xing Xie; Wei Zheng
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.